Renaissance Technologies’s Cyclacel Pharmaceuticals CYCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-87
Closed -$44K 3570
2024
Q1
$44K Buy
87
+27
+45% +$13.7K ﹤0.01% 3501
2023
Q4
$39K Buy
60
+8
+15% +$5.2K ﹤0.01% 3495
2023
Q3
$66K Buy
52
+5
+11% +$6.35K ﹤0.01% 3342
2023
Q2
$101K Hold
47
﹤0.01% 3466
2023
Q1
$97K Hold
47
﹤0.01% 3499
2022
Q4
$112K Hold
47
﹤0.01% 3577
2022
Q3
$245K Buy
47
+29
+161% +$151K ﹤0.01% 3293
2022
Q2
$68K Buy
+18
New +$68K ﹤0.01% 3940
2020
Q3
Sell
-48
Closed -$798K 3425
2020
Q2
$798K Buy
48
+30
+167% +$499K ﹤0.01% 2658
2020
Q1
$498K Hold
18
﹤0.01% 2759
2019
Q4
$850K Buy
18
+2
+13% +$94.4K ﹤0.01% 2703
2019
Q3
$464K Buy
16
+1
+7% +$29K ﹤0.01% 2893
2019
Q2
$596K Buy
15
+7
+88% +$278K ﹤0.01% 2921
2019
Q1
$565K Buy
8
+5
+167% +$353K ﹤0.01% 2887
2018
Q4
$127K Buy
3
+1
+50% +$42.3K ﹤0.01% 3203
2018
Q3
$185K Buy
2
+1
+100% +$92.5K ﹤0.01% 3166
2018
Q2
$130K Buy
+1
New +$130K ﹤0.01% 3123
2018
Q1
Hold
0
3330
2017
Q3
Sell
-1
Closed -$184K 3226
2017
Q2
$184K Sell
1
-1
-50% -$184K ﹤0.01% 3008
2017
Q1
$526K Sell
2
-1
-33% -$263K ﹤0.01% 2760
2016
Q4
$953K Buy
3
+1
+50% +$318K ﹤0.01% 2554
2016
Q3
$983K Buy
2
+1
+100% +$492K ﹤0.01% 2576
2016
Q2
$224K Buy
+1
New +$224K ﹤0.01% 3016
2016
Q1
Hold
0
-$73K 3204
2015
Q4
Hold
0
3141
2015
Q3
Hold
0
-$88K 3196
2015
Q2
Hold
0
3102
2015
Q1
Hold
0
-$37K 3190
2014
Q4
Hold
0
2895